View of Analysis of the Effect of Bevacizumab as An Anti-VEGFR Pathway Drug in the Clinical Treatment of Lung Cancer

Return to Article Details Analysis of the Effect of Bevacizumab as An Anti-VEGFR Pathway Drug in the Clinical Treatment of Lung Cancer Download Download PDF